-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HmIPeNIAxQ/myMxBrRA8XcQ2zac15tDA4AftaWlpsFe1V9PfogRJ8k8q2Rs1pN9t ynqdIqhC1BmvPwLFti+PXA== 0001179022-08-000019.txt : 20080207 0001179022-08-000019.hdr.sgml : 20080207 20080207092232 ACCESSION NUMBER: 0001179022-08-000019 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20080205 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20080207 DATE AS OF CHANGE: 20080207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENTIVA HEALTH SERVICES INC CENTRAL INDEX KEY: 0001096142 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 364335801 STATE OF INCORPORATION: DE FISCAL YEAR END: 0101 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15669 FILM NUMBER: 08583253 BUSINESS ADDRESS: STREET 1: 3 HUNTINGTON QUADRANGLE 2S CITY: MELVILLE STATE: NY ZIP: 11747-8943 BUSINESS PHONE: 6315017000 MAIL ADDRESS: STREET 1: 3 HUNTINGTON QUADRANGLE 2S CITY: MELVILLE STATE: NY ZIP: 11747-8943 FORMER COMPANY: FORMER CONFORMED NAME: OLSTEN HEALTH SERVICES HOLDING CORP DATE OF NAME CHANGE: 19991001 8-K 1 form8k020508.htm FORM 8-K Gentiva Form 8-K

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 5, 2008


GENTIVA HEALTH SERVICES, INC.
(Exact Name Of Registrant As Specified In Charter)


         

Delaware
(State of Incorporation)

 

1-15669
(Commission File No.)

 

36-4335801
(I.R.S. Employer
Identification No.)

3 Huntington Quadrangle, Suite 200S
Melville, New York 11747-4627

(Address of principal executive offices, including zip code)

(631) 501-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

:  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

:  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

:  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

:  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

Item 1.01       Entry into a Material Definitive Agreement.

On February 5, 2008, Gentiva CareCentrix, Inc. ("CareCentrix"), a subsidiary of Gentiva Health Services, Inc., and CIGNA Health Corporation ("CIGNA") entered into a Ninth Amendment, dated February 4, 2008 (the "Amendment"), to the Managed Care Alliance Agreement between CareCentrix and CIGNA dated as of January 1, 2004, as previously amended (the "Agreement").  The Amendment extends the term of the Agreement to January 31, 2011 with automatic renewals thereafter for successive one year terms until either party provides at least 90 days written notice prior to the beginning of the next term. A copy of the press release regarding the foregoing is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

(d)       The following exhibit is filed with this report:

Exhibit No.

Description

99.1

Press Release dated February 7, 2008.

 

 

 

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  GENTIVA HEALTH SERVICES, INC.
(Registrant)
Date: February 7, 2008
        /s/ Stephen B. Paige                                      
  Stephen B. Paige
Senior Vice President, General Counsel and
Secretary
   

 

 


 

EXHIBIT INDEX

Exhibit
 Number

        Description        
99.1

Press release dated February 7, 2008.

 

 

 

EX-99 2 ex991form8k020508.htm EXHIBIT 99.1 PRESS RELEASE Exhibit 99.1

Exhibit 99.1


Press Release

Financial and Investor Contact:
John R. Potapchuk
631-501-7035
john.potapchuk@gentiva.com

Media Contact:
David Fluhrer
631-501-7102, 516-589-0778
david.fluhrer@gentiva.com

FOR IMMEDIATE RELEASE

Gentiva® Health Services and CIGNA HealthCare
Extend National Homecare Contract through January 31, 2011

Melville, NY, February 7, 2008 -- Gentiva Health Services, Inc. (NASDAQ: GTIV), the nation's leading provider of comprehensive home health services, announced today that its CareCentrix® ancillary care benefit management unit has signed an extension of its current national homecare contract with CIGNA HealthCare, which will provide for the coordination and delivery of homecare services to CIGNA members through January 31, 2011. The extension amends a previous agreement that was set to expire January 31, 2009.

CareCentrix has been the largest national provider of homecare and related services to CIGNA HealthCare members since 1996. The extension calls for CareCentrix to continue to coordinate the provision of direct home health services, including home infusion therapy services and certain specialty medical equipment to CIGNA HealthCare members through the CareCentrix network of nearly 4,000 credentialed provider locations. For the first nine months of 2007, the CIGNA HealthCare relationship contributed approximately 19% of total Gentiva revenues of $915.9 million.

"CIGNA HealthCare and CareCentrix have enjoyed a longstanding and mutually beneficial relationship in the delivery of homecare services to CIGNA members," said Gentiva Chairman and CEO Ron Malone. "We're pleased that CIGNA HealthCare has once again recognized CareCentrix' excellence in care coordination and customer service by agreeing to this early contract extension. We're proud of the outstanding work performed each day by the CareCentrix team in serving all of its managed care customers."

 


 

About Gentiva Health Services, Inc.

Gentiva Health Services, Inc. is the nation's leading provider of comprehensive home health and related services. The Company serves patients across the United States, through its direct service delivery units or through CareCentrix®, which manages home health services for major managed care organizations. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; respiratory therapy and home medical equipment; infusion therapy services; and other therapies and services. Gentiva's revenues are generated from federal and state government programs, commercial insurance and individual consumers. For more information, visit Gentiva's web site, http://www.gentiva.com, and its investor relations section at http://investors.gentiva.com. GTIV-G

Forward-Looking Statement

Certain statements contained in this news release, including, without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "assumes," "trends" and similar expressions, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based upon the Company's current plans, expectations and projections about future events. However, such statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others: the Company's ability to successfully execute its growth strategy; the impact of significant indebtedness on the Company's liquidity and its ability to meet the requirements of its creditors; general economic and business conditions; demographic changes; changes in, or failure to comply with, existing governmental regulations; legislative proposals for healthcare reform; changes in Medicare and Medicaid reimbursement levels; effects of competition in the markets in which the Company operates; liability and other claims asserted against the Company; ability to attract and retain qualified personnel; availability and terms of capital; loss of significant contracts or reduction in revenues associated with major payer sources; ability of customers to pay for services; business disruption due to implementation of new business systems, or due to natural disasters or terrorist acts; a material shift in utilization within capitated agreements; and changes in estimates and judgments associated with critical accounting policies and estimates. For a detailed discussion of certain of these and other factors that could cause actual results to differ from those contained in this news release, please refer to the Company's various filings with the Securities and Exchange Commission (SEC), including the "Risk Factors" section contained in the Company's annual report on Form 10-K for the year ended December 31, 2006.

# # #

 

GRAPHIC 3 gentivalogo.jpg begin 644 gentivalogo.jpg M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$" M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#_\``$0@`/@#?`P$1``(1`0,1`?_$`+$```(!!`(#```````` M```````("0$"!PH$!@,%"P$``00#`0$```````````````$"!`4#!@<("1`` M``8!`P(%`P$&!`,)`````0(#!`4&!P`1""$2,4$3%`E182(5<8&1H3)"\",6 M%U(S"M%R)#0E)S<8>!$``0,"!`0"!@H"`00#`````1$"`P`$(3$2!4%1$P9A M(G&!H3(4!_"1L<'1X4(C,Q52"/&"DJ)3-"46_]H`#`,!``(1`Q$`/P#?R*FF M(!NF3P#H)2CMT_8/AK"SWJ6K%"HD$NY2%#81$.TH`(!MX]/OK-Y`R]=6E,EW_CT_$3```';V[>(;>6VE)>&>4*U:Q:XOB.FYJ7'K^ZNH M260J##N!:2]WI\8]*4IC-9&SPC%BNT,'K&0;E=1[UF]:FV,1=FY0=(B42@(;+(* M*)&_$=^@[:QR1EI_=U+XA/NJ))%>1E+MCHWJ4#@00*Y!CAVB`&*8P@/;N`]1 M\]]OIH8X.]W):;ID,),+E=S.7LKD%_I+X?TAX>'AY?;2'.@*@U8N2KM)2T:* M*-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-%%&BBC111HHHT44:**-% M%>#U>TH#V&'J!0`-MQ'H'AU'Q'6*'SL$F6"I2\=/ZD4>."I2'<_?D*P'\?&( MU,FYCDUWLS*J.8S'F-()5J:YY&L"2(+#'0K9YVK9[G=IPV)ITC,G$!3X5OWRT^6G+G`GW M1XG*M$WF)\RO.;F$Z9S4QE1WA;!T]:3Q*&%<$VE:"GFT"S7;>]-/S*'M[1/2 M3B/5$J"ZZR+51SOV($(';KKFS=K;79.:R\:LB8G`D^M,O`?E7T>^7W^OW8_9 ML#H6V<.Z=QQ,UOGN6M=$'88-!#'#A[IS!QI8):`PM8;CRS=TO`G)K+-0A,7- MGV.9RYR\L%RPO/G19+/;WE(I1<'=UTKT5O037$QC(@(B`@8QB68,]K'$^=EH M.J[2,'$C,J4=R%;E%'O<>S[1!>7=C871OW=81:M,S>F_2UAU/`*AI\SOTGPK MD5#E%D;CB?CO+4JR897^./:GZ)Q*D/-M\[5N;$.N+ M8:F#%/;AZ.2KRY5XC^6W3?J(=?X:$XT-<78IY>=7Z:IY4ZK._[#IR8>-(-1.6'JJH& M`1VZZ;YEQ&'JIR$57?30]7(E%4$VP[;#K(E-.K@%H[@Z!YCI$/JIP!131W?; MSV_GH"TUIU+X5=I`5&.%+1I"2`J44#TT.=I"T53?_'33E`SHHWTBCA0E&^EI M"0*-_'IX==)BJ)A2X*G&J";8!';PV_GH&+M-*`I2J[_8=(YR%`%I"@HW^PZ> M`M*`M&^F$N'`T)1O]M*2@6DJNA<%HKK=GL,/4:[.VRQ/$(VOU:%D[%-2+@Q2 M(,(B&8+R4D\6,8=BI-F;4YQ'R`NGQ1&9[619.M17R\>??.BU\V^3N0>4$M;C,2UBTMZ]@/',A%C(1U?Q5&.W@QRG:N! MXA!Z\$I7DB50@G?VI7U\^5?RYL^P.RX M-@@A=UKBTZ\]PU!(V1S0YS<`7'%Y`14#0*5ZOPQZS>H2O2HUUIDNS6['-@I^ M0C6-HI5:0ZEI]F^"1L#9NDNQ69HKJ$4<)*%$J)";"42[AJSFD,T7Q$F#JWV\ MECFVN62SZ\NVPP$/:0YKWXA?>:%_[34GV69UU6\T\[6G(GG;&U[(]GP?5XYF M[P7$L$:7G43UXXL:$]8LFCP&SF,121:K-D5DW)O=J'];M*8FM6A;;OL[0V]F MY.N??(7W3S`KB5E8[;?]H[/'LVR2264=^XNBN'1B6+R/5S=;&+B?TM7&ESY2 MJ7:`Q3PX>9PR3B[.-+#!\LPQS2,:NXV&G<:LG:4>=@UNKZ+)ZLN\8JJI)@LL M"(**H'(*?>0QSVECT_C[SH6[XIA(=1/NG']*`?:>%;IVF^WEW_>3L<%Q;3MN M1U99%+9`'_QA&L(#<2I)!U88TF?Z;*PJ=5I%JML)6J\N@.1XJ7B$V\T]82;V M/,>,(N^B`)*(OE56Y2E3%0?;J'`X>'2V`=<6QBF&%=#=%:7LDE]90F69R03P MR%(G@^1V#@!CYLR5YM\.FL3D.9-,YRX_O&..,A23I4IW]IB#LA M<4BZN?[E'\AH&"98"I@2Y*HX*%*I9HQ$RBK9 MLV!4YTS.%'FM8=*"\1C/,_97GV-DT>J*0?MJ MK3S"?BMS?98C<>T=Q[1Z:I7;_`QQ_9D=XZ2A]&%6HV8D M>>9K7=TVGO[%5\BL&B[QWCR^0YH*Q^W:`3WBS,A5W;-\ M5D*A06*54JJ7<`F(`#OJ7:;Q;WLPMXV/9*BXM(&'BB5%N=LDM&]4O#XU3`K] M8X4R>8XI2:U9HT0K-S*,(T3?RRC-)1%$Q6+15RT3<+`=])PUQ6HX;JICX* M(KH32B*I!^I3"'WU1OW^W`U=&1PYAI0^RK+^FE4K*UIY+3'\;.<6)^4=IGZE M0*UE.$DJY")3[U>^4E6LQZK)5Z5@4C)V=\[*Y=`L\Y3Y;WA[+L8<:E"-IHZ: MT,@U<='6,6E^;65PKEB[-J#5_].Q:,D5. M<=@CZ9Y7UGK(6C$!<%`5">J;Q_'42XOF1/$7$E*?#;22@N;P"US>17(FF<9: M(WR%?8FX3,*ZL,=6DVM&KY[+,ED)-%TJ@J>.*Y:G!D0&9^]0##VB)=PZZS7< MK8H=1IL<1>]!2-N/F+XO-#MR/*=GYFHZ4]%JF]Q?[11TMT$4&I'$ZF9RX+W= M4R=QO#IUU2R;]:0NZ6G'"\+!-U6K%S(*?J4F,FN#(IT6AP((D-N<0#H(ZSV^ZVD\K6- MBD!0C_:,W!6QP*H7OW,&VV^ MVZWEXRTB#W4V"V?.\EO`4PD;(LY>-8RL>X2=L)-DTD6+M$>Y%RS>H$!1ZS&/ADW#X MI?6`%!$2'V*/:.H-YN4%D/W:E6ME+=DB,+34&D&A&!Y,SI`(\C3WWO`.!F_M M/1]Q[D%"B)3(^C^8&#H)1WU,$@TZCRJ(&.U::PI5>16/K<_LD?'#-(+5EI(O MG17D68IW;:+17<._:(-EW+HCL$FJAB-ETT7"H$-V$'M-MC9GW`Q3`0\?)* MDW`=MC^8=-;'VQ!U]VM&O"L)&'!?&NL?(/9[7??FMM%I<$MBBN'3>8*"8!U$ M0_I5H\"*T<\>8OR,CG+BO1Q^/VES-JQK@ESD>SXY?3[=NAR$H[UN[0@Y#(51 M%.KN5J38)!I)4UZPK/Z;9YF?9$,]6(Q2B#)N(YNF9P90=QH);^*VM;1DMW*X M];B'$Y$?Y>-<4O\`NOMG:]JV5LW=FXGK71(D$4Y?*U7-4I*L:/1I)+O*.1P6 MI\WR%&V'XXXRS_&1AV0"RX;M=9IL(G;JGME5ZXJ,1)FGK4*L.=O5EH>+0-+J M-Y8'RY1D5SIK`IV[3VR,N&WP;>SAW6!:@>$1X)3S8*,#S%=!8;5UUW,^S[FO M8]%Y&Z72R73"!."C&B8:M9&@EJ(,2",*C=L]$NK;C3FJ#6X:TZ"7P#R2BF"8^VIAR!1,4TT?3)6Z!0ZE&%[C$!C7ZY`13,A$@.L/:@S9-42[;G-L M'F(ZNW.;:-TN`$0&"9`TO3`+BS?(UT3@9"0$7G MX5(,-P(M;@[I>RNF?(H&_"7DAT$1#'+[8-@$>CU@'3<0*`B`^(]`#KK!O(/] M=,1P&'U5DVUQ%VQ.=+UPXY@<3Z1Q;P74;GFO&T':J_CV%C9Z'DY%-.0CI%`B MGKM7:9FO<19,1Z@.H^W7MM%81Q/XVMR^]D>QKBU1]@I]<3Y MOPOF@DTMB"_5*])5]9JA.*59P1R6+4?)**-$WAB))]HN0;J"4.NX%^VK>*YB ME;I802G"JJ6*5A1P(J-?Y1J]"6[+'`JJV6/1EJ]9LWR4%-Q;@#>C(14F6N-7 MC50"F(;91)4=MC`("&X#N&M>W^W^)DM&G$EV/_CGSJ]V*01173W`$M9@O#WL MJ]#Q?L\[P4Y.37"/(\@[6PYE"4?6SC-;Y%011:N)=RHJM35G!MDTE7+DIT3% M#8"R!0,'1T73K6X.W7_]=*28Y#Y>0]'U\*Q7<0W&T%U%_*!YDSP^BUVGY61# M]9X1;#U_^S,(`#YC^47T_:';K-NP'Q4$3`A#U)YA,O;6+:E9#,UV)Z?WU+ZH MBDKN15)-4O0W:H0IR]VX]=C`(;_?5VYK71@.`(7B%JI!.K,U$3\FS5JCE'@$ M5)LW3*IR1;`<"()%`X">O[@<"D`#E'?P'<-:_O;6PRV@B`:'3$%,%&&:9U?; M3+(8YE<[W.9Y&I;P:-$U`4(U;$4`XF!0C=$IP-OMW`<"`8!^^^MD>`V,EN!2 MJ+J2%I5Q]Y,^%1`_)_\`_,7Q\??D2GO]]G=:VU0;OA1;%2$ MP=0(H.K#=(&SV3P0"X!1ZJKK";HW+7GW%0^NEX^+;,SG*_$^JP\XL MXILZ#@Q@=I'KO86%,Y(<1.4WZ(NBGU_O1,`>&H^RW/7MND[$L_Y%9=RC`N2] MN#78_=6`I-$G+'Y2F$6?:0QGPMJY'[LNP'9NLER*I%")G*8#)&X&,M>,3JNL27MB]$PO%$XE`&\, M\=D-L8!?P8D(81\54#[]=]6VT3">TZV!^UDIQ5:<92C,ZOJM6;U-671=M7M&Y%9.S%9NC()/5Q$Z:0 M`&V_74R.T;$')FX)4)]P9"'8>6E'^8?%$GF3XT>6U-A6:C^;;8K>7*+:H)G. MHX=4)\PN"B`)I@)S=[2'5`"AOW>&VMA[=F$.\6ZX-:]#]@/CQKIGR2WYW;OS M2V>[D+7A]T(7%P`:&RD1N<.,S)9YY/QU<=XT&"Y M$VML]<-K?4'RC)\V&EX[D&;E1^K0CIB@B9/=4J;:- M697/!5/:UQ21>7-.=R19@JDNS>P-F5FJHWDY!E'JNF;1H+I.((#)^Y[7(@`& M&B9;7D]G:O,<$A$QQ:QCA[IXZ:Y0-AW[?-HV2Y;M&QW$PNW/!9'`^)`)%#"V M+3&`!J\JMU#)2HP[.RW#."7X"SM[Y3\QB04%A6Q/Y:3LS%B1?MC-V[8JBQ4CB&IC&;EU+ZWMFVQN'3!`C`B.!)VB(JC%(UKI>LM1L(O&]&NV(O>.G%?N\\@[53:3MP71$JQ5EC*#[HQB MALF`#JXB9>_%L!;;])D83!H\X1>'/C72-KL][FWQL[;;:Y-JMK(-:YIB>Z.Y MT)TP0PED1>-.!#0`/*@2MB7_`*>:@4VY_(5R&S%B*WY2O^&\6\?*U0J_;,MI MB>TGF;B^@5E:^HIWK$;LX7_33PK)`HIE(UV`I-NHZ5WJ76NVLLIR.N92X@%6 MXESL#PP(]!KS!_M'N]Y9?+?:^W=YBM8=YN]RFF<(&,8U(I)@PG0UNK]N1GF( M\Q).9-;IX!UW$-Q'KN(;=0V#H(]`$/IYZY<&JJHBX?57@)JD*,2,%R]E0?2-P0,SQ!G*C$QW8[0"!SLJ]-(MFT6N=\N4I@3]N,='NS@`=QFP MJF#<$S!K6+[7:[DVZ*X5L-MINMM-JW^=?0,\,:F(LM;HV7J#)5JP- M(NZ8_O<+[20;$7%Y#V""D2%4$I';%8`79ND]C`=-38P;;#K8F/COHE(/2<,/ M$&J$F2V2-P1S,#Z1A4+>1^/N&^/WR4\(87#M#AZ)&3L;736L/L8K7=HWPZ\U(*HBX_E5W'+)UQ`)8`/C68M)P]&/C57MEZZWG=U/_C'# M[B4\#[*A;R]RDD.0M(X8UC(:1H3/.'>4\'2%7-G:/CBN)W)T3'Y4/C M6SH`[F'[;>0_?6WCS,"NJ5"`0<]2U#Q\GPA_O'\ M?`?3D2CY#_<[K>WEK7=WE:;N!H56G'V5>;0X1V<[79N&'M_&IB1`1'IMX>'[ M^N_WV\-;$1J"'W"*I`H^NH(PR%$_'GS9Y-,I]0D9BC.>,9;.%);'.5%B>_09 M'[M>#9$$?2]U(2JCQJ0I0`?\Q/?IMK6))6;3=/<%Z3P43'$C#VUL(A_LK1@B M3JL.*X99^S&FG^*_%$I4N/S_`#%0,J*!B^AH-C"#[]1LJ8MI61:$#\S*QD,*QB"&VRYD^O73][NGP M6W0B3K2J`N&6>/K%-VJV;-="=_\`%%B?IZJ1_C.A\D7&;$%RJ\S.9!:(SULD9&TS'$ M8X8^JIMZ[:[J\U/D>(0@]W).0^NL=\8[=F/C#S\=M<_8\BL-PO,8)-1#8.P2;1[$7&W7P;`_*"U8A*UAX MOCYG"T#=<,Y/F8E=RUAJS[URX6IRTTB0SAE*4E9_[5RW(!CN6Y4%@Z&$0[MV MWO%ONFV0VLA`F:$R;?_NO:[9T$D;7$J&@`. M<`0#J$8():C-\?Y2E7AEJC64:Y.M"_JTL@N MW5_48J*V(OV=IA(D7\B=1U>W%NPCH!P\,:Z_N-M#<[?*RU9*[;#"6SQQJ)%< M0X^Z0?\`R&=2VV2]UW+O%W/I%>/E;3RIDAPTBX6+DJ6SKZS9LQQ M2P*NJV6L$6W>N$'"2JJS91R"0F-ZW8`:J^ULH;:U$D=S`[KGR@N_Q/-XSKB$ M=GVG9;=VY'?6>[[<'S/%M$PR'4=,Y235.T^;S']7##DHW):Z3L[C+AW&Y@S9 M3\[U5GA.71IU!Q0V9Q%MQ3)J%CXV*A+Z[3346EI9(&Z*!^\J9C>W.4"#_P`P M]Q90,AN+J>"&5K#*?.]?-CP4E/5SK>.T[6WM=]W:3;K*ZL+IUR[69M9CD`.? MGWCF:C\JR13OB?JC*&HUF?Q@WS'HJ1.!>;>>,64@7(JMZ>*Y)=K&H>H90 M$6;HDBP3-Z?>(`(MR#]=QZZHY-H+GGHW3FM)]TGAG4>XW!D\)B;`UBIB.%9+S_P`7*[R`NN";K-6B`;I;'_`"'[:E7%JVYD:\YM/*L-M=NM6.8T`AX2F=[. MHCOY[@`>6_\`V[]=3"6N&@YU!#2W$JI&0#S^OE_$?Y[ZLFC2$JO.-*WR)XMUSD78\)V2=M$Y M77&$+ZG?H=O#MX]=*:>D,P,#&2%ZFH=%J/L`#N2V/L8=0[JS;<.&KAC4F&X= M"K6H5%-)T$-OW#^_4MN0:,PGLJ-F32K.JV[V]ET07+@>53;6]?:@ZAHJOP[=-C$0D:Q MB(QFB4")-6$:V2:,VZ90V`")((@7]FK!C&QA&U#<2XJT/3;%+X";>#<[> MR]D9),2-!P]:?A4F*Y=%&YC/U9TX0%V+L/7J([^'B(CX?OU,`$+`&A4J,I6E M(Y9<0JAROAJ*SG;-/T>P8XMJ5NJEOJR+$\U'.BH@FNS(+XATO:N5D4%3;;&! M1N00VVU#GM&3SAQP/HJ3!=/@!3$&FB!@^"#&-_5EOU,8GV/Z[[=#W'O_`&?M M_P!7]I_Y;U_H^(=0\ M_KHC)#E&=-3$NXD)ZJ6;EAQ*P5S,Q+,86SY3FMKJ$J!G;)4NS6?K$XBD9)A9 M:G,D(=U"SL?ZH]BB?X*%,)%2G3,)1LK"^N=MG^+MW$=LKH\$J6Q0 M;YPV454;`*A`.80*F/^1A4*&%#B/\2N!KHVW=Z;7_3[:W;> MY]NNI+*[;W*@%$I0*$>7N6RV MQLIN)^N^;AA@1B2`U,\DJMW#YU_+SLVZW3<=YWV/[.6';3\?O9/8\C_MU$ M/D0=!*K&W(K+.@!T8@B5(B!#"4>:[UW-<[@'00ES;4\.)]/(>OTUXH^;W^P6 M^_,B/^HV9ALNR8G.#86GSO;@!U'*XA0,6AY'B!%,0*(D#<`Z=1WZ^/GU MUJS0`=0P->>'-:]FDCR%#^%>0I"E_I#;;IXC^WSTXDNSI4!=J_4E7;:0XX&E M`3*K>TN^^P;Z``,J;I"KQJO:'CMHXKQI4JNBESJFP:*1!1L&BA!1L&@894$` MYT;!XZ;I"KQI>"<*!`!TZA:KHHJFP?3QT<5HXKQHV#_'VTB!5XT>-5VTM(@H MTA`.=+5-M]+2$`YU712U3;2$+G2`)1L&E&&`IRFC8-(@75QI#CG5=M+Q7C2( M*\91'8/Q-X!_P?3_`+VL+/>IU6G$=R[%'?KL`]NP]0^A]9')F"9#TKPJI-Q#Z#T[_#;?KO]>N@:0<,136]-S3I5O/GZ\Q] M5
-----END PRIVACY-ENHANCED MESSAGE-----